Mainz Biomed Bv Stock Price Prediction

MYNZ Stock  USD 0.23  0.02  9.52%   
At this time, the RSI of Mainz Biomed's share price is approaching 46. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Mainz Biomed, making its price go up or down.

Oversold Vs Overbought

46

 
Oversold
 
Overbought
The successful prediction of Mainz Biomed's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Mainz Biomed BV, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Mainz Biomed's stock price prediction:
EPS Estimate Next Quarter
(0.20)
EPS Estimate Current Year
(0.75)
EPS Estimate Next Year
(0.48)
Wall Street Target Price
2
EPS Estimate Current Quarter
(0.19)
Using Mainz Biomed hype-based prediction, you can estimate the value of Mainz Biomed BV from the perspective of Mainz Biomed response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mainz Biomed to buy its stock at a price that has no basis in reality. In that case, they are not buying Mainz because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Mainz Biomed after-hype prediction price

    
  USD 0.22  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Mainz Biomed Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.132.5911.12
Details
Naive
Forecast
LowNextHigh
0.010.258.78
Details
2 Analysts
Consensus
LowTargetHigh
8.809.6710.73
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.2-0.2-0.2
Details

Mainz Biomed After-Hype Price Prediction Density Analysis

As far as predicting the price of Mainz Biomed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mainz Biomed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mainz Biomed, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Mainz Biomed Estimiated After-Hype Price Volatility

In the context of predicting Mainz Biomed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mainz Biomed's historical news coverage. Mainz Biomed's after-hype downside and upside margins for the prediction period are 0.01 and 8.75, respectively. We have considered Mainz Biomed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.23
0.22
After-hype Price
8.75
Upside
Mainz Biomed is dangerous at this time. Analysis and calculation of next after-hype price of Mainz Biomed BV is based on 3 months time horizon.

Mainz Biomed Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Mainz Biomed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mainz Biomed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mainz Biomed, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.36 
8.53
  0.01 
 0.00  
8 Events / Month
9 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.23
0.22
4.35 
42,650  
Notes

Mainz Biomed Hype Timeline

Mainz Biomed BV is now traded for 0.23. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Mainz is estimated to decline in value after the next headline, with the price expected to drop to 0.22. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -4.35%, whereas the daily expected return is now at -0.36%. The volatility of related hype on Mainz Biomed is about 80282.35%, with the expected price after the next announcement by competition of 0.23. About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.72. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mainz Biomed BV recorded a loss per share of 1.11. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 8 days.
Check out Mainz Biomed Basic Forecasting Models to cross-verify your projections.

Mainz Biomed Related Hype Analysis

Having access to credible news sources related to Mainz Biomed's direct competition is more important than ever and may enhance your ability to predict Mainz Biomed's future price movements. Getting to know how Mainz Biomed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mainz Biomed may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
APDNApplied DNA Sciences(0.13)7 per month 0.00 (0.30) 10.69 (21.05) 65.66 
STIMNeuronetics(0.08)7 per month 7.31  0.03  8.99 (9.24) 59.07 
PREPrenetics Global 0.00 9 per month 4.36 (0.01) 9.93 (7.40) 28.16 
FONRFonar(0.14)6 per month 0.00 (0.08) 2.15 (2.97) 10.60 
GTHGenetron Holdings(0.02)1 per month 2.49 (0.04) 3.45 (4.08) 14.43 
OLKOlink Holding AB 0.01 10 per month 0.48  0.05  1.58 (1.37) 4.37 
MDXHMDxHealth SA ADR(0.02)7 per month 0.00 (0.15) 4.48 (5.99) 27.04 
NOTVInotiv Inc 0.02 3 per month 4.37  0.17  14.07 (6.98) 36.53 
STRRPStar Equity Holdings 0.00 0 per month 0.00 (0.09) 2.21 (2.36) 14.03 
LABStandard Biotools 0.14 9 per month 0.00 (0.10) 6.62 (7.11) 17.67 
BDSXBiodesix 0.01 8 per month 0.00 (0.10) 5.95 (5.61) 29.48 
NDRAENDRA Life Sciences(1.08)4 per month 0.00 (0.10) 12.41 (19.58) 111.83 
SERASera Prognostics 1.07 9 per month 0.00 (0.04) 9.55 (7.61) 27.67 
DRIODarioHealth Corp(0.02)10 per month 0.00 (0.09) 8.99 (7.00) 27.55 
BNRBurning Rock Biotech 0.35 3 per month 0.00 (0.04) 11.63 (7.67) 34.58 
LMDXLumiraDx 0.06 1 per month 0.00 (0.14) 11.54 (10.71) 34.05 

Mainz Biomed Additional Predictive Modules

Most predictive techniques to examine Mainz price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mainz using various technical indicators. When you analyze Mainz charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Mainz Biomed Predictive Indicators

The successful prediction of Mainz Biomed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mainz Biomed BV, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mainz Biomed based on analysis of Mainz Biomed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mainz Biomed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mainz Biomed's related companies.
 2021 2022 2023 (projected)
Graham Number5.766.472.7
Receivables Turnover32.512.042.53

Story Coverage note for Mainz Biomed

The number of cover stories for Mainz Biomed depends on current market conditions and Mainz Biomed's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mainz Biomed is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mainz Biomed's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Mainz Biomed Short Properties

Mainz Biomed's future price predictability will typically decrease when Mainz Biomed's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mainz Biomed BV often depends not only on the future outlook of the potential Mainz Biomed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mainz Biomed's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding16.2 M
Cash And Short Term Investments7.1 M

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.